Immunic Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Selling, General & Admin	16.01	15.26	30.55	10.33	14.52	2.4	13.31	11.22	12.35	10.86	Upgrade
Research & Development	83.22	71.26	61.12	38.64	22.51	9.6	39.34	30.05	39.77	39.48	Upgrade
Other Operating Expenses	0	32.97	0	0	0	0	0	0	0	0	Upgrade
Operating Expenses	99.22	119.49	91.67	48.97	37.03	12	52.66	41.27	52.12	50.34	Upgrade
Operating Income	-99.22	-119.49	-91.67	-48.97	-37.03	-12	-52.66	-41.27	-52.12	-50.34	Upgrade
Interest Expense / Income	0	0	0	0	0	-0	0	0	0	0	Upgrade
Other Expense / Income	-5.61	0.92	1.28	-4.95	-2.1	-0.45	-0.58	-0.3	-0.1	-2.68	Upgrade
Pretax Income	-93.61	-120.41	-92.95	-44.02	-34.93	-11.54	-52.08	-40.97	-52.02	-47.67	Upgrade
Net Income	-93.61	-120.41	-92.95	-44.02	-34.93	-11.54	-52.08	-40.97	-52.02	-47.67	Upgrade
Preferred Dividends	0	0	0	0	0	0	0	0	0	9.15	Upgrade
Net Income Common	-93.61	-120.41	-92.95	-44.02	-34.93	-11.54	-52.08	-40.97	-52.02	-56.82	Upgrade
Shares Outstanding (Basic)	44	32	24	16	8	1	1	1	1	0	Upgrade
Shares Outstanding (Diluted)	44	32	24	16	8	1	1	1	1	0	Upgrade
Shares Change	39.29%	34.53%	51.00%	102.84%	811.77%	-15.01%	26.99%	24.79%	56.67%	2974.86%	Upgrade
EPS (Basic)	-2.11	-3.78	-3.93	-2.81	-4.52	-13.63	-52.40	-52.40	-82.80	-141.60	Upgrade
EPS (Diluted)	-2.11	-3.78	-3.93	-2.81	-4.52	-13.63	-52.40	-52.40	-82.80	-141.60	Upgrade
Free Cash Flow	-71.16	-65.26	-83.3	-46.27	-28.56	-9.77	-41.08	-36.33	-52.29	-42.23	Upgrade
Free Cash Flow Per Share	-1.61	-2.05	-3.52	-2.95	-3.70	-11.54	-41.22	-46.30	-83.16	-105.23	Upgrade
EBITDA	-93.5	-120.33	-92.86	-43.98	-34.88	-11.53	-51.08	-39.16	-50.7	-46.58	Upgrade
Depreciation & Amortization	0.11	0.08	0.09	0.04	0.05	0.02	1	1.81	1.33	1.09	Upgrade
EBIT	-93.61	-120.41	-92.95	-44.02	-34.93	-11.54	-52.08	-40.97	-52.02	-47.67	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).